Effects of Iron Supplements on the Oral Bioavailability of Moxifloxacin, a Novel 8-Methoxyfluoroquinolone, in Humans
- 1 January 2001
- journal article
- clinical trial
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 40 (Supplement) , 57-62
- https://doi.org/10.2165/00003088-200140001-00008
Abstract
Objective To investigate the effect of concomitant iron administration on the pharmacokinetics and tolerability of moxifloxacin.Keywords
This publication has 15 references indexed in Scilit:
- Effects of Dairy Products on the Oral Bioavailability of Moxifloxacin, a Novel 8-Methoxyfluoroquinolone, in Healthy VolunteersClinical Pharmacokinetics, 2001
- Evaluation of the Influence of Antacids and H2 Antagonists on the Absorption of Moxifloxacin after Oral Administration of a 400mg Dose to Healthy VolunteersClinical Pharmacokinetics, 2001
- Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in manJournal of Antimicrobial Chemotherapy, 1999
- Absolute bioavailability of moxifloxacinClinical Therapeutics, 1999
- In Vitro and In Vivo Activity of Moxifloxacin against Community Respiratory Tract PathogensClinical Drug Investigation, 1999
- Absorption Interactions With Fluoroquinolones 1995 UpdateDrug Safety, 1995
- FluoroquinolonesDrugs, 1993
- Drug interactions with quinolonesJournal of Antimicrobial Chemotherapy, 1990
- Drug Interactions with QuinolonesClinical Infectious Diseases, 1989
- Inhibition of enoxacin absorption by antacids or ranitidineAntimicrobial Agents and Chemotherapy, 1989